Alternative Weight Loss Options After Discontinuing Medication Due to Neurological Side Effects
Recommended Alternative Medications
- The American Heart Association recommends semaglutide as a first-line treatment for weight loss, with a mean weight loss of 15.8% at 68 weeks, and proven cardiovascular benefits, including a 20% reduction in cardiovascular death, MI, or stroke in patients with pre-existing CVD who are overweight/obese 3
- The European Association for the Study of Obesity suggests liraglutide 3.0 mg as a second GLP-1 option, with a mean weight loss of 5.4% at 56 weeks, and a similar side effect profile to semaglutide but less effective 1, 2
- Naltrexone SR/Bupropion SR is a second-line option, with a mean weight loss of 4.8% at 56 weeks, and no paresthesia risk, making it a good option for patients with depression or on SSRIs 1, 2
- Orlistat is the least effective but safest option, with a mean weight loss of 3.1% at 1 year, and a completely different mechanism of action, with no neurological side effects, making it best for patients with cardiovascular disease who cannot take sympathomimetics 1, 2
Critical Implementation Points
- The American College of Cardiology recommends that pharmacotherapy should never be used alone, but always combined with intensive lifestyle programs, including diet, exercise, and behavioral modification, as weight loss medications work by decreasing appetite, increasing satiation, enhancing satiety, and increasing resting energy expenditure 1, 2, 5
- The Endocrine Society suggests evaluating weight loss at 12 weeks, and discontinuing medication if less than 5% weight loss is achieved, and switching to an alternative medication 1, 2
- Monthly monitoring is recommended for the first 3 months, then every 3 months thereafter, to assess weight loss and adjust treatment as needed 1, 2